These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 36341227)

  • 1. Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China.
    Chen M; Zhang P; Zhao Y; Duolikun N; Ji L
    Diabetes Metab Syndr Obes; 2022; 15():3375-3385. PubMed ID: 36341227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes.
    Miyoshi H; Baxter M; Kimura T; Hattori M; Morimoto Y; Marinkovich D; Tamiwa M; Hirose T
    Diabetes Ther; 2021 May; 12(5):1341-1357. PubMed ID: 33730337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.
    Edelman SV; Ermakova A; Xiong Y; Sieradzan R; Taylor SD
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1420-1431. PubMed ID: 31550190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real-world study of the effect of timing of insulin initiation on outcomes in older medicare beneficiaries with type 2 diabetes mellitus.
    Bhattacharya R; Zhou S; Wei W; Ajmera M; Sambamoorthi U
    J Am Geriatr Soc; 2015 May; 63(5):893-901. PubMed ID: 25955280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study).
    Brož J; Janíčková Ždárská D; Štěpánová R; Kvapil M
    Diabetes Ther; 2019 Apr; 10(2):663-672. PubMed ID: 30788806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of severe hypoglycemia in type 2 diabetes.
    Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
    Curr Med Res Opin; 2018 Jan; 34(1):179-186. PubMed ID: 29017368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice.
    Al Mansari A; Obeid Y; Islam N; Fariduddin M; Hassoun A; Djaballah K; Malek M; Dicker D; Chaudhury T
    BMJ Open Diabetes Res Care; 2018; 6(1):e000519. PubMed ID: 30023075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study.
    Chen P; Ma X; Chen H; Wang K; Zhou L
    Diabetes Metab Syndr Obes; 2020; 13():3059-3068. PubMed ID: 32922056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
    Blonde L; Meneghini L; Peng XV; Boss A; Rhee K; Shaunik A; Kumar S; Balodi S; Brulle-Wohlhueter C; McCrimmon RJ
    Diabetes Ther; 2018 Jun; 9(3):1347-1358. PubMed ID: 29600507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and tolerability of therapy with exenatide once weekly vs basal insulin among injectable-drug-naïve elderly or renal impaired patients with type 2 diabetes in the United States.
    Loughlin AM; Qiao Q; Nunes AP; Öhman P; Ezzy S; Yochum L; Clifford CR; Gately R; Dore DD; Seeger JD
    Diabetes Obes Metab; 2018 Apr; 20(4):898-909. PubMed ID: 29193561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of diabetes care and treatment satisfaction in type 2 diabetes patients treated with a basal-bolus (ICT) insulin regimen in outpatient care: results of the LIVE-COM study].
    Bierwirth RA; Kohlmann T; Moock J; Holle R; Landgraf W
    Med Klin (Munich); 2010 Nov; 105(11):792-801. PubMed ID: 21136237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors.
    Zhang T; Ji L; Gao Y; Zhang P; Zhu D; Li X; Ji J; Zhao F; Zhang H; Guo X
    Diabetes Technol Ther; 2017 Nov; 19(11):675-684. PubMed ID: 29090977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus.
    Zhang P; Zhang H; Li X; Chen M; Wang D; Ji L
    Endocrinol Diabetes Metab; 2020 Apr; 3(2):e00122. PubMed ID: 32318640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.
    Caputo S; Maran A; Mannino D; Morano S; Lastoria G; Nicoziani P
    Minerva Endocrinol; 2015 Dec; 40(4):249-58. PubMed ID: 26551483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study.
    Kim SS; Kim IJ; Kim YK; Yoon KH; Son HY; Park SW; Sung YA; Baek HS
    Diabetes Metab J; 2015 Dec; 39(6):481-8. PubMed ID: 26616594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin.
    Farr AM; Sheehan JJ; Davis BM; Smith DM
    Patient Prefer Adherence; 2016; 10():1471-9. PubMed ID: 27540280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
    Blonde L; Raccah D; Lew E; Meyers J; Nikonova E; Ajmera M; Davis KL; Bertolini M; Guerci B
    Diabetes Ther; 2018 Jun; 9(3):1169-1184. PubMed ID: 29675797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study).
    Gupta A
    Curr Diabetes Rev; 2019; 15(6):510-519. PubMed ID: 31713476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia.
    Beljić Živković TM; Đinđić BJ; Šuluburić Toljić DŽ; Vulović KTM; Udovičić DL; Zdravković DZ
    Diabetes Ther; 2019 Feb; 10(1):71-80. PubMed ID: 30450529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.